Promoting Equity in Eligibility for Registration on the Kidney Transplantation Waiting List: Looking beyond eGFRcr.
作者信息
Levey Andrew S, Inker Lesley A, Goyal Nitender
机构信息
William B. Schwartz Division of Nephrology, Tufts Medical Center, Boston, Massachusetts.
出版信息
J Am Soc Nephrol. 2021 Mar;32(3):523-525. doi: 10.1681/ASN.2020121802.
Abstract
摘要
相似文献
1
Promoting Equity in Eligibility for Registration on the Kidney Transplantation Waiting List: Looking beyond eGFRcr.促进肾移植等待名单登记资格的公平性：超越估算的肾小球滤过率（eGFRcr）进行考量。
J Am Soc Nephrol. 2021 Mar;32(3):523-525. doi: 10.1681/ASN.2020121802.
2
Performance of the 2021 Race-Free CKD-EPI Creatinine- and Cystatin C-Based Estimated GFR Equations Among Kidney Transplant Recipients.2021 年 Race-Free CKD-EPI 基于肌酐和胱抑素 C 的估算肾小球滤过率方程在肾移植受者中的表现。
Am J Kidney Dis. 2022 Oct;80(4):462-472.e1. doi: 10.1053/j.ajkd.2022.03.014. Epub 2022 May 16.
3
Racial Disparities in Eligibility for Preemptive Waitlisting for Kidney Transplantation and Modification of eGFR Thresholds to Equalize Waitlist Time.种族差异与肾移植优先候补资格及 eGFR 阈值调整以均衡候补时间。
J Am Soc Nephrol. 2021 Mar;32(3):677-685. doi: 10.1681/ASN.2020081144.
4
Performance of cystatin C- and creatinine-based estimated glomerular filtration rate equations depends on patient characteristics.基于胱抑素C和肌酐的估算肾小球滤过率方程的性能取决于患者特征。
Clin Chem. 2015 Oct;61(10):1265-72. doi: 10.1373/clinchem.2015.243030. Epub 2015 Aug 3.
5
Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test.单独使用胱抑素 C 或联合使用肌酐作为确证试验估算肾小球滤过率。
Nephrol Dial Transplant. 2014 Jun;29(6):1195-203. doi: 10.1093/ndt/gft509. Epub 2014 Jan 20.
6
Comparison of Estimated Glomerular Filtration Rate with Both Serum Creatinine and Cystatin C (eGFRcr-cys) versus Single Analyte (eGFRcr or eGFRcys) Using CKD-EPI and MDRD Equations in Tertiary Care Hospital Settings.在三级保健医院环境中，使用 CKD-EPI 和 MDRD 方程比较血清肌酐和胱抑素 C（eGFRcr-cys）与单一分析物（eGFRcr 或 eGFRcys）估算肾小球滤过率的比较。
J Coll Physicians Surg Pak. 2020 Jul;30(7):701-706. doi: 10.29271/jcpsp.2020.07.701.
7
Discrepant glomerular filtration rate trends from creatinine and cystatin C in patients with chronic kidney disease: results from the KNOW-CKD cohort.慢性肾脏病患者的肌酐和胱抑素 C 肾小球滤过率趋势差异：来自 KNOW-CKD 队列的结果。
BMC Nephrol. 2020 Jul 16;21(1):280. doi: 10.1186/s12882-020-01932-4.
8
Overestimation of glomerular filtration rate calculated from creatinine as compared with cystatin C in patients with type 2 diabetes receiving sodium-glucose cotransportor 2 inhibitors.与胱抑素 C 相比，2 型糖尿病患者接受钠-葡萄糖共转运蛋白 2 抑制剂治疗时，基于肌酐计算的肾小球滤过率被高估。
Diabet Med. 2022 Jan;39(1):e14659. doi: 10.1111/dme.14659. Epub 2021 Aug 2.
9
Assessment of kidney dysfunction with cystatin C- and creatinine-based estimated glomerular filtration rate and predicting type 2 diabetes: Toranomon Hospital Health Management Center Study 21.基于胱抑素 C 和肌酐的肾小球滤过率估算值评估肾功能障碍与 2 型糖尿病的预测：Toranomon 医院健康管理中心研究 21。
Diabetes Res Clin Pract. 2016 Mar;113:60-8. doi: 10.1016/j.diabres.2016.01.026. Epub 2016 Feb 1.
10
Creatinine- and cystatin C-based estimated glomerular filtration rate slopes for the prediction of kidney outcome: a comparative retrospective study.基于肌酐和胱抑素 C 的估算肾小球滤过率斜率预测肾脏结局：一项比较性回顾性研究。
BMC Nephrol. 2019 Jun 11;20(1):214. doi: 10.1186/s12882-019-1403-1.
引用本文的文献
1
CKD Progression From the Time of Estimated GFR-Based Waitlist Eligibility and Racial Disparities in Transplant Access.从基于估计肾小球滤过率的等待名单资格确定之时起的慢性肾脏病进展及移植机会中的种族差异。
Am J Kidney Dis. 2022 Jun;79(6):841-848.e1. doi: 10.1053/j.ajkd.2021.08.010. Epub 2021 Sep 17.
Zotero 插件